Role of gender and estrogen receptors in the rat aorta endothelium-dependent relaxation to red wine polyphenols.
Regular intake of moderate amounts of beverages rich in polyphenols such as red wine is associated with a protective effect on the vascular system, in part, by increasing the endothelial formation of nitric oxide (NO), a major vasoprotective factor. Since estrogens are potent inducers of NO formation and polyphenols have been shown to have phytoestrogen properties, we determined whether estrogen receptors mediate the stimulatory effect of red wine polyphenols (RWPs) on the endothelial formation of NO using isolated rat aortic rings and cultured endothelial cells. RWPs caused endothelium-dependent relaxations, which were more pronounced in the aorta of female than male rats. Increased relaxations were also observed to acetylcholine but not to sodium nitroprusside. Relaxations to RWPs were abolished by nitro l-arginine and MnTMPyP, markedly reduced by polyethyleneglycol-catalase and wortmannin, and not affected by the estrogen antagonist ICI 182,780 in aortic rings from males and females. eNOS expression was higher in aortic sections of female than male rats. RWPs caused the phosphorylation of Akt and eNOS in endothelial cells, which was unaffected by ICI 182,780. Thus, RWPs cause redox-sensitive PI3-kinase/Akt-dependent NO-mediated relaxations, which are more pronounced in the aorta of female than male rats; an effect most likely due to the increased expression level of eNOS rather than activation of estrogen receptors.
Kane
Modou Oumy
MO
Laboratoire de Pharmacologie et Physiopathologie Cardiovasculaires, UMR CNRS 7175, Faculté de Pharmacie, Université Louis Pasteur de Strasbourg, Illkirch, France.
Anselm
Eric
E
Rattmann
Yanna Dantas
YD
Auger
Cyril
C
Schini-Kerth
Valérie B
VB
D000109:Acetylcholine / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001011:Aorta; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002478:Cells, Cultured; D003331:Coronary Vessels; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000502:physiology; D004730:Endothelium, Vascular / Q000502:physiology*; D004958:Estradiol / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology; D005260:Female; D005419:Flavonoids / Q000032:analysis / Q000494:pharmacology*; D016166:Free Radical Scavengers / Q000494:pharmacology; D008297:Male; D009569:Nitric Oxide / Q000502:physiology*; D020030:Nitric Oxide Donors / Q000494:pharmacology; D052250:Nitric Oxide Synthase Type III / Q000037:antagonists & inhibitors / Q000378:metabolism; D051058:Oncogene Protein v-akt / Q000378:metabolism; D010636:Phenols / Q000032:analysis / Q000494:pharmacology*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010766:Phosphorylation; D059808:Polyphenols; D051381:Rats; D017208:Rats, Wistar; D011960:Receptors, Estrogen / Q000502:physiology*; D012727:Sex Characteristics; D013552:Swine; D014664:Vasodilation / Q000502:physiology*; D014920:Wine / Q000032:analysis*
D004965:Estrogen Antagonists; D005419:Flavonoids; D016166:Free Radical Scavengers; D020030:Nitric Oxide Donors; D010636:Phenols; D000081082:Phosphoinositide-3 Kinase Inhibitors; D059808:Polyphenols; D011960:Receptors, Estrogen; D009569:Nitric Oxide; D004958:Estradiol; D052250:Nitric Oxide Synthase Type III; D051058:Oncogene Protein v-akt; D000109:Acetylcholine